Latest On Achieve Life Sciences, Inc (ACHV):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-28 15:15 EST | News | Achieve: Exciting Smoking Cessation Drug Approval Could Come Soon | N/A |  |
| 2023-05-25 17:16 EST | News | Achieve Life Sciences stock down on pricing $16.5M stock offering | N/A | |
| 2023-05-23 08:15 EST | News | Achieve Life stock rises 10% as cytisinicline helps quit smoking in phase 3 trial | N/A | |
| 2023-05-17 13:31 EST | News | Achieve Life Sciences refinances outstanding loan | N/A | |
| 2023-05-09 23:31 EST | News | Achieve Life Sciences GAAP EPS of -$0.50 beats by $0.19 | N/A | |
About Achieve Life Sciences, Inc (ACHV):
Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes of cytisinicline for smoking cessation and nicotine addiction in the United States and internationally. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain to help reduce the severity of nicotine withdrawal symptoms. It has license agreements with Sopharma AD and University of Bristol. The company is based in Vancouver, Canada.
General
- Name Achieve Life Sciences, Inc
- Symbol ACHV
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 13
- Last Split Factor1:20
- Last Split Date2020-07-31
- Fiscal Year EndDecember
- IPO Date1995-10-13
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Gic SubIndustryBiotechnology
- Web URLhttp://www.achievelifesciences.com
Valuation
- Price/Book (Most Recent Quarter) 2.06
- Enterprise Value EBITDA 0.36
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate -$4.21
- Next Year EPS Estimate -$3.40
- Next Quarter EPS Estimate -$2.15
- Return on Assets -30%
- Return on Equity -53%
- Earnings Per Share -$2.61
- Revenue Per Share $0
- Quarterly Earnings Growth 0%
Highlights
- Market Capitalization 78.23 million
- EBITDA -16347000
- Analyst Target Price $45.2
- Book Value Per Share $6.10
Share Statistics
- Shares Outstanding 6.15 million
- Shares Float 6.09 million
- % Held by Insiders 48%
- % Held by Institutions 15.13%
- Shares Short 427562
- Shares Short Prior Month 459782
- Short Ratio 1.95
- Short % of Float 7%
- Short % of Shares Outstanding 7%
Technicals
- Beta 1.28
- 52 Week High $18.26
- 52 Week Low $5.44
- 50 Day Moving Average 12.8
- 200 Day Moving Average 9.77
Dividends
- Dividend Date 2020-07-31
- ExDividend Date N/A
- Dividend Yield 0%
Achieve Life Sciences, Inc (ACHV) Dividend Calendar:
ACHV's last dividend payment was made to shareholders on July 31, 2020.
Achieve Life Sciences, Inc (ACHV) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
Achieve Life Sciences, Inc (ACHV) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
Achieve Life Sciences, Inc (ACHV) Chart:
Achieve Life Sciences, Inc (ACHV) News:
Below you will find a list of latest news for Achieve Life Sciences, Inc (ACHV) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Achieve Life Sciences, Inc (ACHV) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
Latest ACHV Trades:
Achieve Life Sciences, Inc (ACHV) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | View |
|---|---|---|
| 2020-10-22 | 8-K (Current report) | |
| 2020-10-21 | 8-K (Current report) | |
| 2020-10-13 | 3 (Initial statement of beneficial ownership of securities) | |
| 2020-09-30 | 8-K (Current report) | |
| 2020-08-20 | 8-K (Current report) | |
| 2020-08-19 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-08-19 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-08-06 | 8-K (Current report) | |
| 2020-08-06 | 10-Q (Quarterly report [Sections 13 or 15(d)]) | |
| 2020-08-05 | 424B5 (Prospectus [Rule 424(b)(5)]) | |
| 2020-08-05 | 8-K (Current report) | |
| 2020-08-03 | 424B5 (Prospectus [Rule 424(b)(5)]) | |
| 2020-07-30 | 8-K (Current report) | |
| 2020-06-29 | 424B5 (Prospectus [Rule 424(b)(5)]) | |
| 2020-06-29 | 8-K (Current report) | |
| 2020-06-29 | 424B5 (Prospectus [Rule 424(b)(5)]) | |
| 2020-06-16 | EFFECT (Notice of Effectiveness) | |
| 2020-06-12 | CORRESP (Correspondence) | |
| 2020-06-11 | UPLOAD (SEC-generated letter) | |
| 2020-06-05 | S-1 (General form for registration of securities under the Securities Act of 1933) | |
Achieve Life Sciences, Inc (ACHV) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Achieve Life Sciences, Inc (ACHV). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 48%
Institutional Ownership: 1513%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2020-08-18 | John Bencich | CFO & COO | Buy | 69.00 | 174.00 | | ||
| 2020-08-18 | CINDY JACOBS | EVP, CMO | Buy | 69.00 | 209.00 | | ||
| 2019-08-13 | John Bencich | CFO & COO | Buy | 1,370.00 | 2,509.00 | | ||
| 2019-06-11 | ARMISTICE CAPITAL, LLC | 10% Share Holder | Sell | 0.00 | 1,004,138.00 | | ||
| 2019-06-11 | ARMISTICE CAPITAL, LLC | 10% Share Holder | Sell | 2,200.00 | 3.02 | 6,644.00 | 1,004,138.00 | |
| 2019-06-11 | ARMISTICE CAPITAL, LLC | 10% Share Holder | Sell | 0.00 | 1,006,338.00 | | ||
| 2019-06-11 | ARMISTICE CAPITAL, LLC | 10% Share Holder | Sell | 2,918.00 | 3.17 | 9,250.06 | 1,006,338.00 | |
| 2019-06-11 | ARMISTICE CAPITAL, LLC | 10% Share Holder | Sell | 0.00 | 1,009,256.00 | | ||
| 2019-06-11 | ARMISTICE CAPITAL, LLC | 10% Share Holder | Sell | 5,944.00 | 3.38 | 20,090.72 | 1,009,256.00 | |
| 2019-06-11 | ARMISTICE CAPITAL, LLC | 10% Share Holder | Sell | 0.00 | 1,013,187.00 | | ||
| 2019-06-11 | ARMISTICE CAPITAL, LLC | 10% Share Holder | Sell | 31,897.00 | 3.30 | 105,260.10 | 1,013,187.00 | |
| 2019-06-11 | ARMISTICE CAPITAL, LLC | 10% Share Holder | Sell | 0.00 | 1,015,200.00 | | ||
| 2019-06-11 | ARMISTICE CAPITAL, LLC | 10% Share Holder | Sell | 800.00 | 3.61 | 2,888.00 | 1,015,200.00 | |
| 2019-06-11 | ARMISTICE CAPITAL, LLC | 10% Share Holder | Sell | 0.00 | 1,016,000.00 | | ||
| 2019-06-11 | ARMISTICE CAPITAL, LLC | 10% Share Holder | Sell | 10,000.00 | 3.64 | 36,400.00 | 1,016,000.00 | |
| 2019-06-11 | ARMISTICE CAPITAL, LLC | 10% Share Holder | Buy | 0.00 | 1,026,000.00 | | ||
| 2019-06-11 | ARMISTICE CAPITAL, LLC | 10% Share Holder | Buy | 12,813.00 | 3.80 | 48,689.40 | 1,026,000.00 | |
| 2019-06-11 | ARMISTICE CAPITAL, LLC | 10% Share Holder | Sell | 0.00 | 1,045,084.00 | | ||
| 2019-06-11 | ARMISTICE CAPITAL, LLC | 10% Share Holder | Sell | 21,118.00 | 4.29 | 90,596.22 | 1,045,084.00 | |
| 2019-06-11 | ARMISTICE CAPITAL, LLC | 10% Share Holder | Sell | 0.00 | 1,066,202.00 | |